Metastasis of Invasive Ductal Carcinoma of the Breast to the Uterine Cervix 30 Years Post-Mastectomy: A Case Report.

J Obstet Gynaecol ResSep 30, 2026

Taro Miyake, Hidenori Sasa, Tsubasa Ito et al.

✦ AI-curated · Sources linked

Case in brief

A 69-year-old woman, 30 years post-mastectomy for invasive ductal carcinoma, presented with abnormal cervical cytology. Imaging revealed a 38-mm cervical mass, leading to a modified radical hysterectomy. Histological analysis confirmed metastatic invasive ductal carcinoma, with a notable receptor conversion to HER2-positive status, despite the primary tumor being hormone receptor-positive.

What made this case unusual

This case is notable for the cervical metastasis occurring 30 years after the initial breast cancer surgery, highlighting a rare long-term metastatic presentation.

Diagnostic / clinical pearl

Clinicians should consider metastatic breast cancer in the differential diagnosis of cervical masses in breast cancer survivors, regardless of the time elapsed since the primary diagnosis.

Why it matters

This case emphasizes the need for receptor re-evaluation in metastatic lesions, which is crucial for guiding targeted therapy.

Source

Published in J Obstet Gynaecol Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.